Assessment of pain during application of nasal-continuous positive airway pressure and heated, humidified high-flow nasal cannulae in preterm infants

Osman, M.A.; Elsharkawy, Ashraf; Abdel‐Hady, Hesham

doi:10.1038/jp.2014.206

Cited by 59 publications

(49 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Low-flow nasal cannula is commonly used in pediatrics. A comparison of HFNC with nasal CPAP (nCPAP) in preterm infants showed lower pain scores and less-physiologic stress response [17]. Attempts to use higher flows increase the risk of desiccation and mucosal compromise.…”

Section: Comparison With Other Modes Of Oxygen Delivery and Respiratomentioning

confidence: 99%

High-flow nasal cannula therapy beyond the perinatal period

Lee

Nagler

2017

Current Opinion in Pediatrics

View full text Add to dashboard Cite

show abstract

Section: Comparison With Other Modes Of Oxygen Delivery and Respiratomentioning

confidence: 99%

High-flow nasal cannula therapy beyond the perinatal period

Lee

Nagler

2017

Current Opinion in Pediatrics

View full text Add to dashboard Cite

show abstract

“…91,93,95 Two additional studies did not assess respiratory failure, but compared pain and/or discomfort scores; an observational cross-sectional study in 60 preterm infants revealed that the application of HFNC was associated with less pain compared with nCPAP, 97 whereas a randomized crossover study in 20 preterm infants revealed no differences during treatment. 92 Collins et al 90 randomly assigned 132 mechanically ventilated preterm infants <32 weeks' gestational age to HFNC at 8 L/minute or nCPAP at either 7 or 8 cm H 2 O, depending on supplemental oxygen requirement.…”

Section: Hfnc Versus Cpap For Noninvasive Respiratory Support Of Pretmentioning

confidence: 99%

Noninvasive Respiratory Support

Polin¹,

Watterberg²,

Cummings³

et al. 2016

Pediatrics

View full text Add to dashboard Cite

Mechanical ventilation is associated with increased survival of preterm infants but is also associated with an increased incidence of chronic lung disease (bronchopulmonary dysplasia) in survivors. Nasal continuous positive airway pressure (nCPAP) is a form of noninvasive ventilation that reduces the need for mechanical ventilation and decreases the combined outcome of death or bronchopulmonary dysplasia. Other modes of noninvasive ventilation, including nasal intermittent positive pressure ventilation, biphasic positive airway pressure, and high-fl ow nasal cannula, have recently been introduced into the NICU setting as potential alternatives to mechanical ventilation or nCPAP. Randomized controlled trials suggest that these newer modalities may be effective alternatives to nCPAP and may offer some advantages over nCPAP, but effi cacy and safety data are limited.

show abstract

“…This approach has several reported advantages over CPAP, including reduced rates of nasal trauma [7][8][9] and reduced infant pain scores. 10 Surveys show that it is preferred by parents 11 and nursing staff. 12 In a previous randomized trial comparing high-flow therapy with CPAP as respiratory support after extubation in infants born at a gestational age of less than 32 weeks, we found that high-flow therapy was noninferior to CPAP in preventing treatment failure.…”

mentioning

confidence: 99%